Alleviation of autoimmune disease in MRL-lpr mice by administration of Ye19.1, a monoclonal specific for the lpr T cell antigen, LTA
- 1 October 1991
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 4 (5) , 755-768
- https://doi.org/10.1016/0896-8411(91)90171-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Alleviation of autoimmunity in BXSB mice by monoclonal alloantibody to Ly‐5 (CD45)European Journal of Immunology, 1989
- The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic DomainsScience, 1988
- Unique cell surface phenotypes of proliferating lymphocytes in mice homozygous for lpr and gld mutations, defined by monoclonal antibodies to MRL/Mp-lpr/lpr T cellsCellular Immunology, 1987
- Abnormal tyrosine phosphorylation on T-cell receptor in lymphoproliferative disordersNature, 1986
- Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.The Journal of Experimental Medicine, 1985
- A monoclonal antibody (100C5) to the Lyt‐2− T cell population expanding in MRL/Mp‐lpr/lpr mice detects a surface antigen normally expressed on Lyt‐2+ cells and B cellsEuropean Journal of Immunology, 1982
- Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.The Journal of Experimental Medicine, 1981
- Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.The Journal of Experimental Medicine, 1981
- Murine systemic lupus erythematosusImmunology Today, 1981
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970